Current treatment of cholinesterase inhibitors poisoning: misconceptions and need for updated Peruvian guidelines

Authors

  • Manuel André Virú Loza Médico Residente de Pediatría, Servicio de Pediatría. Hospital Nacional Daniel Alcides Carrión del Callao, Perú; Asociación para el Desarrollo de la Investigación Estudiantil en Ciencias de la Salud (ADIECS-UNMSM), Lima, Perú

DOI:

https://doi.org/10.15381/anales.v76i4.11414

Keywords:

Organophosphorus Compounds, Carbamates, Cholinesterase, Organophophorus Poisoning, Atropine, Pralidoxime Compounds, Pesticides.

Abstract

Millions of cases of cholinesterase inhibitors poisonings occur in the world and thousands of deaths by these substances are reported. Our country is not different scenario. The most useful treatment regimen is currently under research and some extensively used measures are on debate. The current trend is aggressive treatment as severe life-threatening adverse effects by drugs like atropine are very rare. In Peru there is no active research on this issue and only an organophosphate and carbamate poisoning in children treatment guide by the Ministry of Health in 2005 is available. It is urgent to update these guidelines, since they contain concepts that in some cases have radically changed due to current knowledge. The aim of this review is to briefly expose the most relevant updated information on treatment of these poisonings, to suggest evaluation of the mentioned guidelines, and to call attention of the Peruvian Ministry of Health authorities to develop guidelines for adults.

Downloads

Published

2015-12-31

Issue

Vol. 76 No. 4 (2015)

Section

Artículos de Revisión

License

Copyright (c) 2015 Manuel André Virú Loza

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Those authors who have publications with this magazine accept the following terms:

  1. Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
  2. Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
  3. Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).

How to Cite

1.
Virú Loza MA. Current treatment of cholinesterase inhibitors poisoning: misconceptions and need for updated Peruvian guidelines. An Fac med [Internet]. 2015 Dec. 31 [cited 2024 Jul. 6];76(4):431-7. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/11414